Kyowa Kirin (KYKOF) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free KYKOF Stock Alerts $17.63 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineKyowa Kirin (OTCMKTS:KYKOF) Trading 4.8% Higher americanbankingnews.com - April 23 at 1:48 AMKYKOY Kyowa Kirin Co., Ltd.seekingalpha.com - April 19 at 3:03 PMKyowa Kirin Co Ltd (KY4.SG)finance.yahoo.com - April 16 at 12:43 AMKyowa Kirin: First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndromefinanznachrichten.de - April 15 at 9:42 AMFirst Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndromefinance.yahoo.com - April 15 at 9:42 AMKyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ® (istradefylline) and Other Parkinson's Disease Add-On Therapiesfinance.yahoo.com - April 12 at 9:25 AMKyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ® (istradefylline) and Other Parkinson's Disease Add-On Therapiesprnewswire.com - April 12 at 9:00 AMKyowa Kirin Announces Acceptance of Abstract for Presentation at the Association for Research in Vision and Ophthalmology Annual Meeting 2024prnewswire.com - April 2 at 1:15 PMKYKOF Kyowa Kirin Co., Ltd.seekingalpha.com - March 26 at 1:51 PMBreaking Down the $4.3 Million Price Tag Kyowa Kirin’s Gene Therapy for Rare Genetic Diseasemsn.com - March 21 at 5:39 AMKyowa Kirin's gene therapy most expensive US drug with $4.3 million price tagmsn.com - March 20 at 7:38 PMKyowa Kirin's gene therapy most expensive US drug with $4.3 mln price tagreuters.com - March 20 at 8:49 AMKyowa buyout Orchard wins FDA nod for rare disease therapymsn.com - March 19 at 12:59 PMPharma exec talks construction, hiring for new North Carolina plantbizjournals.com - March 18 at 4:41 PMHow NC city lured Japanese pharma Kyowa Kirin's $200M investmentbizjournals.com - March 8 at 10:29 AMKyowa Kirin Will Present Phase 2b Post-hoc Analysis and Symposium at the American Academy of Dermatology Annual Meeting 2024finance.yahoo.com - March 8 at 10:29 AMHow a North Carolina city lured Japanese pharma's $200M investmentbizjournals.com - March 6 at 4:35 PMKyowa Kirin to set up a new plant in Sanford, USAmsn.com - February 28 at 4:23 PMRock Hill misses out on $200M project from Japanese pharmaceutical company Kyowa Kirinbizjournals.com - February 27 at 3:32 PMKyowa Kirin Announce Symposium, Acceptance of Abstract for Presentation at American Academy of Dermatology 2024 Meetingfinance.yahoo.com - February 14 at 10:29 AMKyowa Kirin Announce Symposium, Acceptance of Abstract for Presentation at American Academy of Dermatology 2024 Meetingprnewswire.com - February 14 at 7:00 AMBridgeBio grants Japanese rights to Kyowa Kirin for dwarfism drugmsn.com - February 7 at 3:19 PMBridgeBio Pharma and Kyowa Kirin Announce Partnership with an Upfront Payment of $100 Million for an Exclusive License on Infigratinib in Skeletal Dysplasias in Japanfinance.yahoo.com - February 7 at 3:19 PMKyowa Kirin Announces First Patient Enrolled in the Phase 2 Clinical Trial Evaluating Tivozanib Eye Drops in Patients with Diabetic Macular Edemafinance.yahoo.com - February 6 at 7:08 AMBoehringer Ingelheim, Kyowa Kirin enter license agreement to develop novel treatment for fibro-inflammatory diseasesmsn.com - January 8 at 9:59 AMKyowa Kirin Co Ltdmorningstar.com - December 14 at 2:44 PMKyowa Kirin Co Ltd ADR KYKOYmorningstar.com - November 8 at 10:23 AMKyowa Kirin reports 9M resultsmsn.com - November 1 at 3:45 PMKyowa Kirin Presents Real-World Findings at ASBMR Annual Meeting Highlighting Progressive Disease Burden of X-linked Hypophosphatemia (XLH)finance.yahoo.com - October 16 at 1:27 PMKyowa Kirin to Present New Research on X-linked Hypophosphatemia (XLH) at ASBMR Annual Meetingfinance.yahoo.com - October 12 at 1:55 PMKyowa Kirin Announces Three Abstracts and A Symposium at the European Academy of Dermatology and Venereology Congress 2023finance.yahoo.com - October 11 at 9:32 AMKyowa Kirin to acquire Orchard Therapeutics for $478 mlnreuters.com - October 5 at 7:58 AMOrchard Therapeutics ADSs Soar Premarket on Takeover by Kyowa Kirinmarketwatch.com - October 5 at 7:58 AMKyowa Kirin To Buy Orchard Therapeutics; Orchard Shares Up In Pre-marketmarkets.businessinsider.com - October 5 at 7:58 AMKyowa Kirin to Acquire Orchard Therapeuticsfinance.yahoo.com - October 5 at 7:58 AMKyowa Kirin Announces Acceptance for Presentations at the European Academy of Dermatology and Venereology Congress 2023finance.yahoo.com - October 4 at 5:36 PMTenapanor for Hyperphosphatemia Approved in Japanfinance.yahoo.com - September 25 at 8:29 AMKyowa Hakko Kirin Co. Ltd.wsj.com - September 14 at 6:53 PMTitian Software Supporting Kyowa Kirin’s Central Sample Bankuk.finance.yahoo.com - August 29 at 6:44 PMKyowa Kirin reports H1 resultsmsn.com - August 4 at 5:36 PMKyowa Kirin Designs New North American Headquarters to Accelerate Innovation, Collaboration, Culturefinance.yahoo.com - July 11 at 8:40 AMKyowa Kirin Launches Effort to Educate Healthcare Providers on Blood Involvement in Mycosis Fungoides and Sézary Syndromefinance.yahoo.com - June 13 at 9:27 AMKyowa Kirin Continues Commitment to Making Dreams Possiblefinance.yahoo.com - May 30 at 11:26 AMKyowa Kirin GAAP EPS of ¥23.74, revenue of ¥93.54Bmsn.com - May 12 at 6:14 PMKyowa Kirin Presents New Findings from Real-World Study in Parkinson's Disease at the 2023 IAPRD Conferencemarkets.businessinsider.com - May 12 at 1:14 PMHere's what Wall Street expects from Kyowa Hakko Kogyo's earnings reportmarkets.businessinsider.com - May 10 at 3:48 PMKyowa Kirin Appoints Pharma Industry Leader Steve Schaefer as President, North America to Manage Next Phase of Growthfinance.yahoo.com - April 11 at 12:38 PMEarnings Season Results Deflate Tokyo Sharesmsn.com - February 9 at 6:51 PMFed Chief's Commentary Churns Asian Stock Marketsmsn.com - February 8 at 9:45 AMKyowa Kirin Co., Ltd. GAAP EPS of ¥99.66, revenue of ¥398.37Mseekingalpha.com - February 7 at 5:57 PM Get Kyowa Kirin News Delivered to You Automatically Sign up to receive the latest news and ratings for KYKOF and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide KYKOF Media Mentions By Week KYKOF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KYKOF News Sentiment▼0.000.34▲Average Medical News Sentiment KYKOF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KYKOF Articles This Week▼20▲KYKOF Articles Average Week Get Kyowa Kirin News Delivered to You Automatically Sign up to receive the latest news and ratings for KYKOF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AstraZeneca News Today Cosmo Pharmaceuticals News Today Daiichi Sankyo News Today JCR Pharmaceuticals News Today Mayne Pharma Group News Today Ono Pharmaceutical News Today Otsuka News Today Roche News Today Sanofi News Today Virbac News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:KYKOF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldTrump is sounding the alarmPreserve GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kyowa Kirin Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
